Aspirin's hidden power against a dangerous pregnancy complication revealed
NCT ID NCT06200571
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates how aspirin can prevent preeclampsia, a serious pregnancy condition, in first-time mothers at high risk. Researchers will compare biological changes in 200 women with low or high risk, some taking aspirin and some not. The goal is to understand how aspirin affects the immune system and blood vessels to reduce risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alesund Hospital
Ålesund, 6017, Norway
-
St. Olavs Hospital
Trondheim, 7030, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a placental protein unlock the mystery of preeclampsia?
- Tiny particles in the blood may warn of dangerous pregnancy high blood pressure
- Vitamin d may cut risk of repeat preeclampsia in High-Risk pregnancies
- Depression drug may mend blood vessels damaged by preeclampsia
- Postpartum blood pressure control may stop preeclampsia from leading to lifelong hypertension
- Genetic clues to severe preeclampsia could transform early detection